©2017 City of Hope we've BEEN PIONEERING CAR-T CELL THERAPIES FOR OVER 20 YEARS, AND WE'RE NOT STOPPING NOW. It's a new day for research and patient care in CAR-T cell therapies. City of Hope is investigating CAR-T cell therapies in hard-to-treat blood cancers and solid tumors. We've been accelerating innovative CAR-T research for more than 20 years, developing our own therapies, as well as partnering with global biopharmaceutical companies for clinical trials. We've treated over 150 patients using CAR-T therapies to date and currently have 13 active trials, with several more opening in 2018. City of Hope is one of 16 centers of excellence chosen to provide Kite Pharma's newly approved CAR-T therapy that has shown great promise in the treatment of non-Hodgkin lymphoma. Find out more about City of Hope's CAR-T cell therapies expertise. Go to CityofHope.org/CAR-T or visit us at Booth #1912 in the exhibit hall. Comprehensive Cancer Center A Cancer Center Designated by the National Cancer Institute